| Literature DB >> 25710016 |
Hany M Yehia1, Wesam A Hassanein2, Shimaa M Ibraheim2.
Abstract
Susceptibility of the tested Pseudomonas aeruginosa strain to two different antibiotics, tetracycline (TE) and ciprofloxacin (CIP), was carried out using liquid dilution method. Minimum inhibitory concentrations of TE and CIP were 9.0 and 6.0 mg/100 mL, respectively. Some metabolic changes due to both, the mode of action of TE and CIP on P. aeruginosa and its resistance to high concentrations of antibiotics (sub-MIC) were detected. The total cellular protein contents decreased after antibiotic treatment, while outer membrane protein (OMP) contents were approximately constant for both treated and untreated cells. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the OMPs for untreated and TE and CIP treated cells indicated that the molecular changes were achieved as; lost in, induction and stability of some protein bands as a result of antibiotics treatment. Five bands (with mol. wt. 71.75, 54.8, 31.72, 28.63, and 20.33 KDa) were stable in both treated and untreated tested strains, while two bands (with mol. wt. 194.8 and 118.3 KDa) were induced and the lost of only one band (with mol. wt. 142.5 KDa) after antibiotics treatment. On the other hand, total lipids and phospholipids increased in antibiotic treated cells, while neutral lipids decreased. Also, there was observable stability in the number of fatty acids in untreated and treated cells (11 fatty acids). The unsaturation index was decreased to 56% and 17.6% in both TE and CIP treatments, respectively. The produced amount of EPSs in untreated cultures of P. aeruginosa was relatively higher than in treated cultures with sub-MICs of TE and CIP antibiotics. It was also observed that the amounts of exopolysaccharides (EPSs) increased by increasing the incubation period up to five days of incubation in case of untreated and antibiotic treated cultures.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25710016 PMCID: PMC4331405 DOI: 10.1155/2015/651464
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Effect of increasing concentrations of TE and CIP on growth of the tested P. aeruginosa strain.
| Antibiotic conc. | OD (600 nm) | |
|---|---|---|
| TE | CIP | |
| 0 | 0.67 ± 0.01 | 0.67 ± 0.01 |
| 1 | 0.64 ± 0.01 | 0.61 ± 0.01 |
| 2 | 0.59 ± 0.01 | 0.52 ± 0.01 |
| 3 | 0.51 ± 0.01 | 0.32 ± 0.01 |
| 4 | 0.40 ± 0.01 | 0.11 ± 0.01 |
| 5 | 0.33 ± 0.01 | 0.02 ± 0.01 |
| 6 | 0.23 ± 0.01 |
|
| 7 | 0.10 ± 0.01 | — |
| 8 | 0.03 ± 0.01 | — |
| 9 |
| — |
|
| 10.023 | 6.286 |
|
| <0.001*** | <0.001*** |
t: one sample test, P: P value.
***more highly significant at <0.001.
Effect of sub-MICs of TE and CIP on total cellular proteins and outer membrane proteins contents of the tested P. aeruginosa strain.
| Treatment | Total cellular proteins content (mg/mL) | OMPs content (mg/mL) |
|---|---|---|
| Untreated | 11.3 ± 0.10 | 5.60 ± 0.10 |
| TE (8.0 mg/100 mL) | 8.20 ± 0.10 | 5.40 ± 0.10 |
| CIP (5.0 mg/100 mL) | 7.10 ± 0.10 | 5.60 ± 0.10 |
|
| 14.088 | 125.484 |
|
| <0.001*** | <0.001*** |
t: one sample test, P: P value.
***more highly significant at <0.001.
Molecular weights and amount % of extracted outer membrane proteins of the tested P. aeruginosa strain treated with sub-MICs of TE and CIP.
| Treatment | Untreated | CIP (5.0 mg/100 mL) | TE (8.0 mg/100 mL) | M | ||||
|---|---|---|---|---|---|---|---|---|
| Lanes | Lane 1 | Lane 2 | Lane 3 | Lane 4 | ||||
| Rows | Mol. wt. | Amount% | Mol. wt. | Amount% | Mol. wt. | Amount% | Mol. wt. | Amount% |
|
| ||||||||
| r1 | ||||||||
| r2 | 194.8 | 0.52076 | 194.8 | 1.7818 | ||||
| r3 | 142.52 | 0.9757 | ||||||
| r4 | 118.3 | 28.639 | 118.3 | 14.699 | 120 | 29.606 | ||
| r5 | 86 | 0.79774 | ||||||
| r6 | 78.95 | 8.3631 | ||||||
| r7 | 71.75 | 7.3978 | 71.75 | 14.519 | 71.75 | 8.362 | ||
| r8 | 54.8 | 17.071 | 54.8 | 1.3673 | 54.8 | 7.027 | ||
| r9 | 47 | 0.6413 | ||||||
| r10 | 40.663 | 0.56036 | 40.663 | 1.679 | ||||
| r11 | 33.712 | 6.4954 | 34 | 20.721 | ||||
| r12 | 31.721 | 20.327 | 31.72 | 20.264 | 31.721 | 7.3197 | ||
| r13 | 30.135 | 6.2393 | ||||||
| r14 | 28.635 | 32.422 | 28.635 | 20.573 | 28.635 | 30.652 | ||
| r15 | 28 | 0.36329 | ||||||
| r16 | 20.333 | 0.27476 | 20.333 | 8.2844 | 20.333 | 2.215 | 20 | 1.0261 |
|
| ||||||||
| Sum | 79.03 | 94.168 | 94.8333 | 53.155 | ||||
| In lane | 100 | 100 | 100 | 100 | ||||
Figure 1Outer membrane proteins banding pattern of antibiotics treated and untreated P. aeruginosa strain. M, marker; lane 1, untreated cells; lane 2, treated cells with 5.0 mg/100 mL CIP; and lane 3, treated cells with 8.0 mg/100 mL TE.
Effect of sub-MICs of TE and CIP on lipid fractions of the tested P. aeruginosa strain.
| Lipid fraction | Treatment | ||
|---|---|---|---|
| Untreated | TE (8.0 mg/100 mL) | CIP (5.0 mg/100 mL) | |
| Total lipids (TL) (% of dry wt.) | 10.10 ± 0.10 | 12.70 ± 0.10 | 11.20 ± 0.10 |
| Phospholipids (PL) (as % of TL) | 59.90 ± 0.10 | 62.30 ± 0.10 | 60.90 ± 0.10 |
| Neutral lipids (NL) (as % of TL) | 40.09 ± 0.01 | 37.70 ± 0.10 | 39.10 ± 0.10 |
|
| |||
|
| 5.070 | 5.247 | 5.154 |
|
| <0.01** | <0.01** | <0.01** |
t: one sample test, P: P value.
**highly significant at <0.01.
Effect of sub-MICs of TE and CIP on fatty acids percentages in the tested P. aeruginosa strain.
| Fatty acids (as % of TL) | Untreated | TE (8.0 mg/100 mL) | CIP (5.0 mg/100 mL) | |
|---|---|---|---|---|
| (1) Caproic | C6:0 | — | — | — |
| (2) Caprylic | C8:0 | 2.33 | 3.27 | 3.57 |
| (3) Capric | C10:0 | 1.96 | 10.14 | 2.47 |
| (4) Lauric | C12:0 | 3.03 | 7.09 | 1.23 |
| (5) Myristic | C14:0 | — | 4.49 | — |
| (6) Palmitic | C16:0 | 2.70 | 6.77 | 1.03 |
| (7) Stearic | C18:0 | 2.53 | 4.24 | 3.23 |
| (8) Oleic | C18:1 | 19.17 | 19.03 | 16.68 |
| (9) Linoleic | C18:2 | 24.69 | 12.87 | 23.47 |
| (10) Linolenic | C18:3 | 13.77 | 11.66 | 14.57 |
| (11) Arachidic | C20:0 | 9.24 | 8.99 | 15.56 |
| (12) Eicosadienoic | C20:1 | 13.99 | 5.98 | 12.66 |
| (13) Behenic | C20:0 | 6.56 | — | 5.63 |
|
| ||||
| Unsaturation index | 2.50 | 1.1 | 2.06 | |
Figure 2Effect of sub-MIC of TE and CIP on exopolysaccharides (EPSs) of the tested P. aeruginosa strain at different incubation periods.